Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2009-11-18
Original SEC Filing: Click here

---

Webplus: SVA/20091118/6-K/2_EX-99.1/000.htm SEC Original: a09-33739_2ex99d1.htm
Sinovac Reports Unaudited Third Quarter 2009 Financial Results – Conference call scheduled Monday, November 16, 2009 at 9:00 a.m. ET – BEIJING, Nov. 15 /PRNewswire-Asia/ — Sinovac Biotech Ltd. (Nasdaq: SVA), a leading developer and provider of vaccines, announced today its unaudited financial results for the three-month and nine-month periods ended September 30, 2009. Financial Highlights · Sales for the

---

---

Webplus: SVA/20091118/6-K/1/000.htm SEC Original: a09-33739_26k.htm
SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China Form 20-F x Form 40-F o o o SINOVAC BIOTECH LTD.

---

Company Information:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2009-11-18CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD
BEIJING 100085